USA vs. Europe: Which Will Receive Pfizer’s Coronavirus Vaccine First?

Some 300 million doses have already been secured through advance purchases and mass production is expected to begin before the end of 2020. Challenges lie ahead for distribution.

RIO DE JANEIRO, BRAZIL - The United States and Europe are in line to receive the first doses of an experimental coronavirus vaccine after a partnership between Pfizer and BioNTech yielded excellent preliminary results in a large-scale Subscribe to our Premium Membership Plan. Already Subscribed?